Anti-Tupaia chinensis CD47/MER6 Polyclonal Antibody from ProteoGenix; catalogue ARO-A22189; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Introducing our Anti-Tupaia chinensis CD47/MER6 Polyclonal Antibody – a powerful tool for research in the field of biotechnology. This highly specific antibody targets the CD47 and MER6 proteins in Tupaia chinensis, providing researchers with a valuable tool for studying these important molecules.
CD47 and MER6 are cell surface proteins that play a crucial role in regulating immune responses and cell signaling pathways. CD47 is known to be involved in cell proliferation, apoptosis, and immune evasion, while MER6 is essential for cell survival and differentiation. Our Anti-Tupaia chinensis CD47/MER6 Polyclonal Antibody binds to these proteins, allowing for their detection and analysis in various biological samples.
This antibody is suitable for a wide range of applications, including immunohistochemistry, western blotting, and flow cytometry. It has been extensively tested and validated for use in both human and animal tissues, making it a versatile tool for researchers working with a variety of sample types.
Our Anti-Tupaia chinensis CD47/MER6 Polyclonal Antibody has been used in numerous studies to investigate the role of CD47 and MER6 in various biological processes. Some of the experimental use cases include:
1. Investigating the role of CD47 and MER6 in cancer: This antibody has been used to study the expression of CD47 and MER6 in cancer cells and their potential as therapeutic targets for cancer treatment.
2. Studying immune responses: Researchers have used this antibody to analyze the expression of CD47 and MER6 in immune cells, providing insights into their role in immune regulation.
3. Examining cell signaling pathways: By detecting the presence of CD47 and MER6 in different cell types, this antibody has helped researchers understand the signaling pathways involved in various cellular processes.
In conclusion, our Anti-Tupaia chinensis CD47/MER6 Polyclonal Antibody is a highly specific and reliable tool for studying CD47 and MER6 proteins. Its versatility and proven performance make it an essential asset for any biotech research project. Order now and take your research to the next level.
ProteoGenix catalogue number ARO-A22189. For research use only.
Target: leukocyte surface antigen CD47; CD47; Clonality: Polyclonal Antibody; Applications: IHC, ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| leukocyte surface antigen CD47; CD47 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
